VIII INTERNATIONAL MEETING ON CANCER INDUCED BONE DISEASE
SYDNEY 2009 – SCIENTIFIC PROGRAM
Click here for a program at a glance (as of August 4, 2008)
Session 1 | Session 2 | Session 3| CABS Plenary 1 | Session 4 | CABS Plenary 2
Session 5 | Session 6 | Session 7 | Session 8
WEDNESDAY 25 MARCH 2009
08:00 - Registration opens
08:30 - SESSION 1
IBMS / ANZBMS - CABS joint Symposium
Cancer and Bone Symposium
Chairs:
08:30 - IS1 - Pathophysiology of bone metastasis
Theresa Guise (USA)
09:00 - IS2 - Micrometastases as predictors of bone metastasis in breast cancer
R.Charles Coombes (UK)
09:30 - IS3 - Management of cancer and bone - trials and tribulations
Sandy Patterson (USA)
10:00 – 10:30 - Refreshment Break Room
10:30 - SESSION 2
IBMS / ANZBMS - CABS joint Symposium
Cancer and Bone Orals
Chairs:
10:30 - OR1
10:42 - OR2
10:54 - OR3
11:06 - OR4
11:18 - OR5
11:30 - OR6
11:42 - OR7
11:54 - OR8
12:06 - OR9
12:18 - OR10
12:30 – 13:30 - Lunch
13:30 - SESSION 3
Multiple Myeloma and Myeloproliferative Disease
Chairs:
13:30 - IS5 - Mechanisms in myeloma bone disease
Masahiro Abe (Japan)
14:00 - IS6 - The bone microenvironment and myeloproliferative disease
Louise Purton (Australia)
14:30 - OR11
14:42 - OR12
CABS Plenary 1
14:54 - IS6 - Epidermal and endothelial growth factors in cancer progression and as therapeutic targets
Isaiah Fiddler (USA)
15:30 – 17:00 - Refreshments and Posters
17:00 – 18:30 - Commercial Symposium
19:00 – 11:30 - Conference Dinner: including awards
THRUSDAY 26 MARCH 2009
08:00 - Registration opens
08:30 - SESSION 4
Bisphosphonates in therapy
Chairs:
CABS Plenary 2
08:30 - IS7 - Bisphosphonates as an adjuvant in breast cancer treatment
Michael Gnant (Austria) (Note: session ends at 9:10)
09:40 - OR13
09:52 - OR14
10:04 – 10:30 - Refreshment Break Room
10:30 - SESSION 5
IBMS / ANZBMS - CABS joint Symposium
EMT and cancer spread
Chairs:
10:30 - IS9 - Epithelial-mesenchymal transition and its significance for bone metastasis formation
Jean-Paul Thiery (Singapore)
11:00 - IS10 - Genetic predictors of prostate cancer aggression
Jianhua Luo (USA)
11:30 - IS11 - Lung cancer organ-specific metastases including bone
Saburo Sone (Japan)
12:00 - OR15
12:12 - OR16
12:24 - OR17
12:30 – 13:30 - Lunch Room
13:30 - SESSION 6
Drug therapies
Chairs:
13:30 - IS12 - Clinical applications of bone markers in assessing patients with cancer
Markus Seibel (Australia)
14:00 - IS13 - Skeletal effects of anticancer treatments, and their management
Peter Ebeling (Australia)
15:00 - OR18
15:12 - OR19
15:24 - OR20
15:36 – 16:00 - Refreshments
16:00 – 17:30 - Commercial Symposium
17:30 - SESSION 7
New molecular targets
Chairs:
17:30 - IS14 - Identification of tissue-specific metastasis genes
Yibin Kang (USA)
18:00 - OR21
18:12 - OR22
18:24 - OR23
18:36 - Conference Summary / Close
19:30 – 21:00 - VIP Function (by invitation) Location